Canaan Partners vs Pfizer Venture Investments
Two firms that co-invest: side by side on stage, sector, check size, and track record, from public filings and the firms' own sites.
| Canaan Partners | Pfizer Venture Investments | |
|---|---|---|
| Type | Venture capital | Corporate VC |
| HQ | Stamford | — |
| Founded | 1994 | 2004 |
| Check size | $500K – $20M | $5M – $20M |
| Stages | Pre-Seed, Seed, Series A | Seed, Series A, Series B, Series C, Growth, Late Stage |
| Sectors | Biotech, Cloud Computing, Consumer, Deep Tech, Digital Health, E-commerce, Enterprise Software, Fintech, Gaming, Healthtech, Medical Devices | AI & Machine Learning, Biotech, Healthtech, Medical Devices |
| AUM | $7B | — |
| Tracked investments | 380 | 186 |
| Exits (acquired/public) | 4 | 4 |
| Led rounds on record | 1 | — |
| Dated deals, last 24 mo | 15 | — |
Shared portfolio · 7
Arrakis TherapeuticsAutobahn Therapeutics, Inc.CytomXGrey Wolf TherapeuticsNormunityNextCurevisit ww.nextcure.com
Frequently asked questions
- Do Canaan Partners and Pfizer Venture Investments invest together?
- Yes — Canaan Partners and Pfizer Venture Investments appear together in 7 tracked portfolio companies, including Arrakis Therapeutics, Autobahn Therapeutics, Inc., CytomX, Grey Wolf Therapeutics, Normunity.
- How do Canaan Partners and Pfizer Venture Investments compare on check size?
- Canaan Partners typically writes checks of $500K – $20M, while Pfizer Venture Investments writes $5M – $20M.